Orbimed Advisors, Director: Corvus Pharmaceuticals CRVS Sell · Filed 25/07/01

Trade details

Type: Insider sale
Amount: $4,893,541.12
Shares · price: 1,176,332 sh · $4.16 a share
Held after: 7,165,006 sh
Stock: Corvus Pharmaceuticals CRVS
Person: Orbimed AdvisorsDirector
Trade date: 25/06/27
Filed: 25/07/01
Days to filing: 4 days

Sold 14.1% of holdings

Share of holding sold: 14.1%

Corvus Pharmaceuticals trades, last 26 weeks

What else happened in Corvus Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/05/28~25/07/27

Orbimed Advisors's recent trades

Orbimed AdvisorsDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$10M
588,235 sh
$10M
Filed 09/30
Traded 09/28
Orbimed AdvisorsDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$5.1M
300,249 sh
$5.1M
Filed 09/30
Traded 09/28
Orbimed AdvisorsDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$1M
61,516 sh
$1M
Filed 09/30
Traded 09/28
Orbimed AdvisorsDirector
BuyElectra Therapeutics
Buy
Electra Therapeutics
ETRA
$15M
1,000,000 sh
$15M
Filed 09/23
Traded 09/21
Orbimed AdvisorsDirector
BuyElectra Therapeutics
Buy
Electra Therapeutics
ETRA
$5M
333,333 sh
$5M
Filed 09/23
Traded 09/21